Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation (NCT07308808)
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to determine whether Lactobacillus crispatus strains isolated from the lower urinary tracts of adult women can be used as an antibiotic-sparing treatment for urinary symptoms and urinary tract infection (UTI) among adults with neurogenic lower urinary tract dysfunction (NLUTD). The main question\[s\] it aims to answer are: 1. To identify soluble bactericidal compounds produced by urinary isolates of L. crispatus that kill uropathogenic E. coli (UPEC). 2. To determine if intravesical instillation of L. crispatus is safe and well tolerated in adults with NLUTD due to SCI who use intermittent catheterization (IC). If there is a comparison group: Researchers will compare L. Crispatus to standard care saline to see if there is a difference in urinary symptoms and urinary microbiome. Participants will be asked to complete daily symptom surveys, complete 2 bladder instillations, and collect, freeze, and return 14 urine samples.
Who can join: Review the eligibility criteria below.
Location: Medstar National Rehabilitation Hospital — Washington D.C., District of Columbia
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Medstar National Rehabilitation Hospital — Washington D.C., District of Columbia
📞 Contact the Study Coordinator
Phone: (202) 877-1844
Email: emily.m.leonard@medstar.net
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Spinal Cord Injuries (SCI)
- Radio-frequency (RF) Bladder Monitor — Montreal, Quebec
- Functional Electrical Stimulation Plus High Intensity Interval Training at Home — Toronto, Ontario
- Comparing CPAP and BiPAP for Sleep-Disordered Breathing in People with Cervical Spinal Cord Injuries — Vancouver, British Columbia
- mSCI: Mobile Health App for Veterans With SCI and Caregivers — Pittsburgh, Pennsylvania
- Exploring the Feasibility and Benefits of Implementing Pelvic Floor Muscle Training During Inpatient Rehabilitation for People With Spinal Cord Injury — Vancouver, British Columbia
- Self-balancing Personal Exoskeleton for SCI — The Bronx, New York
Explore by condition: All Spinal Cord Injuries (SCI) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.